Congenital cytoplasmic body myopathy with survival motor neuron (SMN) gene deletion or Werdnig-Hoffman disease?

1997 ◽  
Vol 7 (6-7) ◽  
pp. 430
Author(s):  
J. Vajsar ◽  
V. Jay ◽  
P. Ray ◽  
J. Siegel-Bartelt
Neurology ◽  
1998 ◽  
Vol 51 (3) ◽  
pp. 873-875 ◽  
Author(s):  
J. Vajsar ◽  
T. Balslev ◽  
P. N. Ray ◽  
J. Siegel-Bartelt ◽  
V. Jay

2011 ◽  
Vol 20 (6) ◽  
pp. 1293-1304 ◽  
Author(s):  
Monique A. Lorson ◽  
Lee D. Spate ◽  
Melissa S. Samuel ◽  
Clifton N. Murphy ◽  
Christian L. Lorson ◽  
...  

2011 ◽  
Vol 192 (3) ◽  
pp. 481-495 ◽  
Author(s):  
Anindya Sen ◽  
Takakazu Yokokura ◽  
Mark W. Kankel ◽  
Douglas N. Dimlich ◽  
Jan Manent ◽  
...  

Spinal muscular atrophy (SMA), a devastating neurodegenerative disorder characterized by motor neuron loss and muscle atrophy, has been linked to mutations in the Survival Motor Neuron (SMN) gene. Based on an SMA model we developed in Drosophila, which displays features that are analogous to the human pathology and vertebrate SMA models, we functionally linked the fibroblast growth factor (FGF) signaling pathway to the Drosophila homologue of SMN, Smn. Here, we characterize this relationship and demonstrate that Smn activity regulates the expression of FGF signaling components and thus FGF signaling. Furthermore, we show that alterations in FGF signaling activity are able to modify the neuromuscular junction defects caused by loss of Smn function and that muscle-specific activation of FGF is sufficient to rescue Smn-associated abnormalities.


2007 ◽  
Vol 10 (2) ◽  
pp. 55-60 ◽  
Author(s):  
S Kocheva ◽  
S Vlaski-Jekic ◽  
M Kuturec ◽  
G Efremov

Molecular Analysis of Survival Motor Neuron and Neuronal Apoptosis Inhibitory Protein Genes in Macedonian Spinal Muscular Atrophy PatientsSpinal muscular atrophy (SMA) is classified according to the age of onset and severity of the clinical manifestations into: acute (Werding-Hoffman disease or type I), intermediate (type II) and juvenile (Kugelberg-Wilander disease or type III) forms. All three SMAs have been linked to markers at 5q11.2-q13.3. Two candidate genes deleted in SMA patients are the survival motor neuron (SMN) gene and the neuronal apoptosis inhibitory protein (NAIP) gene. We have performed molecular analyses of these genes in 30 unrelated Macedonian families (17 with type I, eight with type II and five with type III forms of the disease). Deletions of exons 7 and 8 of the SMN gene were found in 76.6% (23/30) of patients (94.1% in type I, 87.5% in type II). Among these 23 families, 19 had both exons deleted, while four had deletions only of exon 7. Deletions of exon 5 of the NAIP gene were found in 41.2% (7/17) patients with type I SMA and in 12.5% (1/8) of patients with type II SMA. No deletions of the SMN gene were found in 30 parents and 30 normal controls. We found 2/30 (6.7%) parents to be homozygous for the deletion of exon 5. Our data support the hypothesis that the telomeric SMN gene plays a major role in determining the clinical course of the disease, while the defects in the NAIP gene have only a modifying effect on the phenotype.


2021 ◽  
Vol 12 (01) ◽  
pp. 210-212
Author(s):  
Divya M. Radhakrishnan ◽  
Ritu Shree ◽  
Govind Madhaw ◽  
Rajat Manchanda ◽  
Anita Mahadevan ◽  
...  

AbstractThe association of spinal muscular atrophy (SMA) with progressive myoclonic epilepsy, also known as “SMA plus,” is a unique syndrome linked to non-survival motor neuron (non-SMN) genes. The disease starts in childhood with progressive weakness and atrophy of muscles; myoclonic epilepsy develops during later childhood, after the onset of motor symptoms. In this report, we describe a case of SMN gene unrelated SMA and myoclonic epilepsy, supported by electrophysiological and neuropathological evidences.


2004 ◽  
Vol 279 (15) ◽  
pp. 14803-14811 ◽  
Author(s):  
Sarmila Majumder ◽  
Saradhadevi Varadharaj ◽  
Kalpana Ghoshal ◽  
Umrao Monani ◽  
Arthur H. M. Burghes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document